Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CPS”

57 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 57 results

Large-scale testing (Phase 3)Study completedNCT01864746
What this trial is testing

Palbociclib in Addition to Standard Endocrine Treatment in Hormone Receptor Positive Her2 Normal Patients With Residual Disease After Neoadjuvant Chemotherapy and Surgery

Who this might be right for
Breast CancerHormonreceptor PositiveHer2-normal+2 more
GBG Forschungs GmbH 1,250
Not applicableLooking for participantsNCT07396259
What this trial is testing

Predicting Clinical Efficacy of Immunotherapy Using Pre-treatment andContinuousMonitoring of PD-L1 TPS/CPS on CTCs, and Immunity Exhaustion Scores

Who this might be right for
Circulating Tumor Cells (CTCs)ImmunotherapyPD-L1 Expression+1 more
Chang Gung Memorial Hospital 150
Not applicableStudy completedNCT01332851
What this trial is testing

Supporting Parents Program: Intervention for Families in CPS

Who this might be right for
Child AbuseChild Neglect
University of Washington 270
Not applicableStudy completedNCT03437837
What this trial is testing

Validation of the CPS+EG, Neo-Bioscore and Modified Neo-Bioscore Staging Systems After PST of BC in China

Who this might be right for
Breast CancerNeoadjuvant TherapyNeoplasm Staging+5 more
Peking University First Hospital 1,077
Not applicableLooking for participantsNCT07378423
What this trial is testing

Questionnaire on Congenital Cancer Signs Through Self-Assessment

Who this might be right for
Cancer Predisposition SyndromesPediatric CancerChildhood Neoplasms+1 more
Insel Gruppe AG, University Hospital Bern 205
Large-scale testing (Phase 3)Looking for participantsNCT07524452
What this trial is testing

Becotatug Vedotin (MRG003) in Combination With PD-1 Inhibitor Versus PD-1 Inhibitor for the Treatment of EGFR-positive, CPS≥1 Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Locally Advanced Head and Neck Squamous Cell Carcinoma
Ming-Yuan Chen 430
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07214987
What this trial is testing

PDT For Induction Therapy For Head And Neck Cancer

Who this might be right for
Squamous Cell CarcinomaHead and Neck Cancer Squamous Cell CarcinomaHead and Neck Cancer
Massachusetts General Hospital 26
Testing effectiveness (Phase 2)Looking for participantsNCT05681039
What this trial is testing

Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab in Patients With Newly Diagnosed PD-L1 CPS Positive Resectable Stage 3-4 Oral Cavity Squamous Cell Carcinoma (OCSCC).

Who this might be right for
Squamous Cell CarcinomaOral Cavity Squamous Cell Carcinoma
M.D. Anderson Cancer Center 29
Testing effectiveness (Phase 2)UnknownNCT04999800
What this trial is testing

Study of Pembrolizumab Combined With Anlotinib in the First Line Therapy for R/M HNSCC With CPS≥1

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Shi Yuankai 20
Large-scale testing (Phase 3)WithdrawnNCT06513884
What this trial is testing

HB-202/HB-201 With Pembrolizumab in Patients With HPV16+ Recurrent/Metastatic Oropharyngeal Cancer

Who this might be right for
Oropharyngeal Squamous Cell Carcinoma Recurrent
Hookipa Biotech GmbH
Large-scale testing (Phase 3)UnknownNCT03629769
What this trial is testing

Effects of Proxelan Somministration in Patients With Chronic Prostatitis

Who this might be right for
Chronic ProstatitisChronic Prostatitis With Chronic Pelvic Pain SyndromePremature Ejaculation
University of Pisa 30
Testing effectiveness (Phase 2)UnknownNCT05075122
What this trial is testing

Tolerability and Efficacy of UV1 Vaccine in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Planned for First-line Treatment With Pembrolizumab

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Martin-Luther-Universität Halle-Wittenberg 75
Not applicableLooking for participantsNCT06870591
What this trial is testing

Pivotal Study for the Cardiac Performance System (CPS)

Who this might be right for
Cardiovascular Diseases
Sensydia Corporation 1,000
Large-scale testing (Phase 3)Looking for participantsNCT06177041
What this trial is testing

M108 Plus CAPOX Versus Placebo Plus CAPOX as First-line Treatment for Claudin (CLDN) 18.2-Positive, HER2-Negative, PD-L1 CPS<5, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma.

Who this might be right for
Locally Advanced Unresectable or Metastatic Gastric CancerLocally Advanced Unresectable or Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
FutureGen Biopharmaceutical (Beijing) Co., Ltd 486
Large-scale testing (Phase 3)Looking for participantsNCT06123884
What this trial is testing

BAT1308 Combined with Platinum-Based Chemotherapy± Bevacizumab for PDL1-Positive (CPS ≥1) Cervical Cancer

Who this might be right for
Cervical Cancer
Bio-Thera Solutions 526
Large-scale testing (Phase 3)Active Not RecruitingNCT06295731
What this trial is testing

INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC)
Inhibrx Biosciences, Inc 410
Large-scale testing (Phase 3)Not Yet RecruitingNCT05715840
What this trial is testing

Efficacy and Safety Study of First-line Treatment With SG001 Plus Chemotherapy ± Bevacizumab Versus Placebo Plus Chemotherapy ±Bevacizumab for Recurrent, or Metastatic Cervical Cancer With PD-L1 Positive (CPS≥1)

Who this might be right for
Recurrent, or Metastatic Cervical Cancer With PD-L1 Positive (CPS≥1)
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 368
Not applicableEnded earlyNCT02896426
What this trial is testing

Collaborative Problem Solving vs. Positive Solutions for Families in Preschool Parent Groups

Who this might be right for
Child BehaviorProblem BehaviorFamily Conflict
Massachusetts General Hospital 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT05287113
What this trial is testing

Study of Retinfanlimab in Combination With INCAGN02385 and INCAGN02390 as First-Line Treatment in Participants With PD-L1-Positive (CPS ≥ 1) Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck Cancer
Incyte Biosciences International Sàrl 176
Not applicableLooking for participantsNCT06755203
What this trial is testing

Evaluating the Impact of Operating Room Simulations on Communication Skills and Patient Safety (EIORS-CPS)

Who this might be right for
Patient-Centered CareCompetency-Based Education
King Saud Medical City 109
Load More Results